BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8781359)

  • 1. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment.
    Harris CC
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):435-9. PubMed ID: 8781359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1995 Deichmann Lecture--p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment.
    Harris CC
    Toxicol Lett; 1995 Dec; 82-83():1-7. PubMed ID: 8597035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.
    Hussain SP; Hollstein MH; Harris CC
    Ann N Y Acad Sci; 2000; 919():79-85. PubMed ID: 11083100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment.
    Hussain SP; Hofseth LJ; Harris CC
    Lung Cancer; 2001 Dec; 34 Suppl 2():S7-15. PubMed ID: 11720736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens.
    Hussain SP; Harris CC
    Mutat Res; 2000 Apr; 462(2-3):311-22. PubMed ID: 10767641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of human cancer.
    Hussain SP; Harris CC
    Recent Results Cancer Res; 1998; 154():22-36. PubMed ID: 10026991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of human cancer.
    Hussain SP; Harris CC
    Toxicol Lett; 1998 Dec; 102-103():219-25. PubMed ID: 10022257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.
    Wogan GN
    Environ Health Perspect; 1992 Nov; 98():167-78. PubMed ID: 1486846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.
    Hussain SP; Harris CC
    Mutat Res; 1999 Jul; 428(1-2):23-32. PubMed ID: 10517975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of p53 transgenic mice in the development of cancer models for multiple purposes.
    Lubet RA; Zhang Z; Wiseman RW; You M
    Exp Lung Res; 2000 Dec; 26(8):581-93. PubMed ID: 11195457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
    Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
    IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis.
    Soussi T; Dehouche K; BĂ©roud C
    Hum Mutat; 2000; 15(1):105-13. PubMed ID: 10612830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 tumor-suppressor gene: clues to molecular carcinogenesis.
    Wang XW; Harris CC
    J Cell Physiol; 1997 Nov; 173(2):247-55. PubMed ID: 9365531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Environmental carcinogens and p53 gene mutation].
    Xu Z; Jin Y
    Wei Sheng Yan Jiu; 2004 Mar; 33(2):239-43. PubMed ID: 15209018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and physical carcinogenesis: advances and perspectives for the 1990s.
    Harris CC
    Cancer Res; 1991 Sep; 51(18 Suppl):5023s-5044s. PubMed ID: 1884379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker.
    Semenza JC; Weasel LH
    Environ Health Perspect; 1997 Feb; 105 Suppl 1(Suppl 1):155-63. PubMed ID: 9114284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations in human cancers.
    Hollstein M; Sidransky D; Vogelstein B; Harris CC
    Science; 1991 Jul; 253(5015):49-53. PubMed ID: 1905840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations?
    Pfeifer GP; Denissenko MF
    Environ Mol Mutagen; 1998; 31(3):197-205. PubMed ID: 9585258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.